You just read:

Mallinckrodt To Acquire Ocera Therapeutics And OCR-002, Its Proprietary Therapy In Development For Treatment Of Hepatic Encephalopathy

News provided by

Mallinckrodt plc

Nov 02, 2017, 06:45 ET